IDT.AX ASX
IDT Australia Limited
1W: -8.9%
1M: -10.9%
3M: +28.1%
YTD: -8.9%
1Y: -36.9%
3Y: -28.7%
5Y: -92.9%
A$0.04 ($0.03)
-0.00 (-6.82%)
Weekly Expected Move ±9.2%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#6
of 16
Drug Manufacturers - Specialty & Generic
Technical Signal Map
1 Bullish
1 Neutral
11 Bearish
IDT.AX
$20M
IDT Australia Limited
BEARISH
-100
PKP.AX
$20M
Peak Processing Limited
LEAN BULL
+18
VLS.AX
$150M
Vita Life Sciences Limited
NEUTRAL
-8
GELS
—
Gelteq Limited Ordinary Shares
BEARISH
-40
ECS.AX
$10M
ECS Botanics Holdings Ltd
BEARISH
-42
EPN.AX
$10M
Epsilon Healthcare Limited
BEARISH
-46
MVP.AX
$50M
Medical Developments International Limited
BEARISH
-59
RGT.AX
—
Argent BioPharma Limited
BEARISH
-66
LGP.AX
$20M
Little Green Pharma Ltd
BEARISH
-74
VIT.AX
$10M
Vitura Health Limited
BEARISH
-91
SNT.AX
$30M
Syntara Limited
BEARISH
-100
PER.AX
—
Percheron Therapeutics Limited
BEARISH
-100
IVX.AX
—
Invion Limited
BEARISH
-100
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| IDT.AX IDT Australia Limited | $20M | -6.4 | -50.8 | -23.0 | -13.2 | 91.2 | 4 | BEARISH | -36.9 |
| PKP.AX Peak Processing Limited | $20M | — | — | — | — | — | — | LEAN BULL | — |
| VLS.AX Vita Life Sciences Limited | $150M | 13.8 | 39.2 | 83.9 | 11.5 | 22.9 | 6 | NEUTRAL | 22.1 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -59.6 |
| ECS.AX ECS Botanics Holdings Ltd | $10M | -4.2 | -30.0 | -36.9 | -11.1 | 14.0 | 2 | BEARISH | -21.4 |
| EPN.AX Epsilon Healthcare Limited | $10M | 86.7 | -16.5 | -30.1 | -9.6 | 147.3 | 5 | BEARISH | -21.2 |
| MVP.AX Medical Developments International Limited | $50M | 75.9 | 1.4 | 12.3 | 4.1 | 24.6 | 8 | BEARISH | -26.7 |
| RGT.AX Argent BioPharma Limited | — | — | — | — | — | — | — | BEARISH | -78.6 |
| LGP.AX Little Green Pharma Ltd | $20M | -15.2 | 10.7 | -2.2 | -2.1 | 104.8 | 6 | BEARISH | -46.1 |
| VIT.AX Vitura Health Limited | $10M | -2.8 | -2.6 | 4.7 | -5.6 | 5.8 | 3 | BEARISH | -71.6 |
| SNT.AX Syntara Limited | $30M | — | — | — | — | — | — | BEARISH | — |
| PER.AX Percheron Therapeutics Limited | — | -1.0 | -233.4 | -503.1 | — | — | 1 | BEARISH | -61.9 |
| IVX.AX Invion Limited | — | -0.6 | -271.4 | -137.9 | -537.3 | — | 2 | BEARISH | -71.5 |
| IDT.AX IDT Australia Limited | $20M | -6.4 | -50.8 | -23.0 | -13.2 | 91.2 | 4 | BEARISH | -36.9 |
| PKP.AX Peak Processing Limited | $20M | — | — | — | — | — | — | LEAN BULL | — |
| VLS.AX Vita Life Sciences Limited | $150M | 13.8 | 39.2 | 83.9 | 11.5 | 22.9 | 6 | NEUTRAL | 22.1 |
| GELS Gelteq Limited Ordinary Shares | — | — | — | — | — | — | — | BEARISH | -59.6 |
| ECS.AX ECS Botanics Holdings Ltd | $10M | -4.2 | -30.0 | -36.9 | -11.1 | 14.0 | 2 | BEARISH | -21.4 |
| EPN.AX Epsilon Healthcare Limited | $10M | 86.7 | -16.5 | -30.1 | -9.6 | 147.3 | 5 | BEARISH | -21.2 |
| MVP.AX Medical Developments International Limited | $50M | 75.9 | 1.4 | 12.3 | 4.1 | 24.6 | 8 | BEARISH | -26.7 |
| RGT.AX Argent BioPharma Limited | — | — | — | — | — | — | — | BEARISH | -78.6 |
| LGP.AX Little Green Pharma Ltd | $20M | -15.2 | 10.7 | -2.2 | -2.1 | 104.8 | 6 | BEARISH | -46.1 |
| VIT.AX Vitura Health Limited | $10M | -2.8 | -2.6 | 4.7 | -5.6 | 5.8 | 3 | BEARISH | -71.6 |
| SNT.AX Syntara Limited | $30M | — | — | — | — | — | — | BEARISH | — |
| PER.AX Percheron Therapeutics Limited | — | -1.0 | -233.4 | -503.1 | — | — | 1 | BEARISH | -61.9 |
| IVX.AX Invion Limited | — | -0.6 | -271.4 | -137.9 | -537.3 | — | 2 | BEARISH | -71.5 |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
IDT.AX vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F